Atlas Trials

Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia

Clinical trial NCT03254173 · COMPLETED

Trial details

NCT number
NCT03254173
Sponsor
Catherine Naseef Hunter
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Advanced CancerCancer Associated Anorexia - Cachexia
Start date
2018-03-26
Primary completion
2019-10-17
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.